Pharmacokinetics of ADWX-1 Peptide in Sprague-Dawley Rats after Single Subcutaneous Administration

杨婷婷,廖建民,江欣,张奉国,徐寒梅

DOI: https://doi.org/10.19526/j.cnki.1005-8915.2012.04.014

2012-01-01

Abstract:To investigate the preclinical pharmacokinetics of ADWX-1 peptide in Sprague-Dawley (SD) rats, an isotopic tracer method coupling with trichloroacetic acid(TCA) precipitation was established. The ADWX-1 peptide was labeled with 125I by Chloramine-T method, Gel filtration HPLC method was used to determine the radiochemical purities of 125I-ADWX-1 peptide and the patch-clamp whole-cell recording mode method was used to measure the bioactivity of 125I-ADWX-1. TCA precipitation method was used to separate the ADWX-1 from its metabolite. The mainl pharmacokinetics parameters of ADWX-1 peptide were calculated with Drug and Statistics (DAS) software. The results show that the radiochemical purities of 125I-ADWX-1 is 96.77%, the bioactivity has no significant difference between 125I-ADWX-1 and ADWX-1 at the same concentration. The lower limit of quantification of the TCA precipitation method was 19.5 ng/mL, and the linear of standard curve ranged from 39 ng/mL to 2, 500 ng/mL. The ADWX-1 peptide was administered to SD rats by single subcutaneous injection; the dosages of ADWX-1 were 50 μg/kg, 100 μg/kg and 200 μg/kg, respectively, in which is including 1.56 × 10 6 Bq/mL 125I-ADWX-1. After single dose of subcutaneous administration, the profile of ADWX-1 peptide in SD rats fits to one compartment model. The half life(T 1/2) of ADWX-1 peptide, was (161.310 ±41.105), (129.832 ± 21.315), (143.021 ±34.727) min, which dont have significant difference between the three dose level. The area under curve(AUC) and C max were(21869.101 ± 4282.617), (41175.180 ± 6699.601), (90543.101 ± 27233.192) μg/min · L and (101.465 ± 16.198), (208.312 ± 19.412), (429.124 ± 104.474) μg/L, respectively. The C max and AUC of ADWX-1 peptide are proportional to the dosage, which suggests that ADWX-1 peptide has the pharmacokinetics linearity over the dose range from 50 μg/kg to 200 μg/kg. The results suggest that ADWX-1 peptide has a linearity pharmacokinetics behavior in SD rats after single dose of subcutaneous administration. ADWX-1 peptide is quite stable in SD rats' blood.